Bakar Bio Labs Reaches $1B Funding Milestone

The North Atlantic Blue Biotech Summit, to be held March 19 in Portland, will bring together biotech startups, policymakers, investors and innovators to help foster growth in the emerging sector.

⚡ Transform Your Battery Innovation into a Scalable Venture! ⚡ 🚀 Calling all researchers, Master’s & PhD students, engineers, and entrepreneurial talents across Germany! The wait is over — the Battery Startup Incubator (BaStI) by TUM Venture Labs launches the first batch of the Battery Venture Course 2026 (16 April – 16 July | Thursdays 16:00–18:30 CET). This hands-on, project-based program goes beyond theory, enabling you to explore the entire battery value chain - from materials and cell technologies to systems integration and recycling - and turn breakthroughs into scalable ventures. 💡 What you’ll gain: -Translate deep-tech innovations into viable business models -Conduct structured customer discovery with industry stakeholders -Develop techno-economic analyses (TEA) to assess feasibility and viability -Integrate regulatory, IP, and financing considerations into venture strategy -Design scaling strategies for capital-intensive technologies -Create and defend investor-ready pitches 👥 Program highlights: -Hybrid format: weekly online sessions + 3 on-campus events at TUM Garching -Mentoring from experienced founders, investors, and industry experts -Hands-on team projects with real battery venture cases -Fireside chats and workshops with battery startup founders and ecosystem leaders 💸 Fully online & free of charge — limited seats available! 📌 Applications open until 27 March 2026 Learn more and apply here 👉 https://lnkd.in/enX-ErQd Don’t just innovate — commercialize your battery breakthrough and shape the future of energy storage! ⚡ #BatteryVentureCourse #DeepTech #BatteryInnovation #Entrepreneurship #TUMVentureLabs #BaStI #MasterStudents #PhDStudents #CustomerDiscovery #TEA #StartupSkills #GlobalOpportunity

Even in a selective venture environment, investors continue to pay a premium for breakthrough science and deep technology emerging from universities. $𝟭𝟭.𝟰𝗕 𝗳𝗹𝗼𝘄𝗲𝗱 𝗶𝗻𝘁𝗼 𝘂𝗻𝗶𝘃𝗲𝗿𝘀𝗶𝘁𝘆 𝗯𝗶𝗼𝗽𝗵𝗮𝗿𝗺𝗮 𝘀𝘁𝗮𝗿𝘁𝘂𝗽𝘀 𝗹𝗮𝘀𝘁 𝘆𝗲𝗮𝗿. That’s despite the broader biopharma VC market 𝗱𝗲𝗰𝗹𝗶𝗻𝗶𝗻𝗴 𝗻𝗲𝗮𝗿𝗹𝘆 𝟮𝟬%. At the same time, 𝗔𝗜 𝘀𝘁𝗮𝗿𝘁𝘂𝗽𝘀 𝗰𝗼𝗺𝗶𝗻𝗴 𝗼𝘂𝘁 𝗼𝗳 𝘂𝗻𝗶𝘃𝗲𝗿𝘀𝗶𝘁𝗶𝗲𝘀 𝗮𝗿𝗲 𝗻𝗼𝘄 𝘀𝗲𝗲𝗶𝗻𝗴 𝗲𝗮𝗿𝗹𝘆-𝘀𝘁𝗮𝗴𝗲 𝘃𝗮𝗹𝘂𝗮𝘁𝗶𝗼𝗻𝘀 𝗿𝗲𝗮𝗰𝗵 ~$𝟭𝟯𝟴𝗠. So what’s actually driving investor conviction here? We’re seeing a clear pattern: 🧬 𝗕𝗿𝗲𝗮𝗸𝘁𝗵𝗿𝗼𝘂𝗴𝗵 𝘀𝗰𝗶𝗲𝗻𝗰𝗲 𝗶𝘀 𝘀𝘁𝗶𝗹𝗹 𝗴𝗲𝘁𝘁𝗶𝗻𝗴 𝗳𝘂𝗻𝗱𝗲𝗱 — even as capital becomes more selective 🤖 𝗔𝗜 & 𝗰𝗼𝗺𝗽𝘂𝘁𝗲 𝗲𝗺𝗲𝗿𝗴𝗶𝗻𝗴 𝗳𝗿𝗼𝗺 𝗮𝗰𝗮𝗱𝗲𝗺𝗶𝗰 𝗹𝗮𝗯𝘀 𝗮𝗿𝗲 𝗿𝗲𝘀𝗵𝗮𝗽𝗶𝗻𝗴 𝘄𝗵𝗲𝗿𝗲 𝗱𝗼𝗹𝗹𝗮𝗿𝘀 𝗳𝗹𝗼𝘄 The gap between “𝗴𝗼𝗼𝗱” 𝗰𝗼𝗺𝗽𝗮𝗻𝗶𝗲𝘀 𝗮𝗻𝗱 𝘁𝗿𝘂𝗹𝘆 𝗱𝗶𝗳𝗳𝗲𝗿𝗲𝗻𝘁𝗶𝗮𝘁𝗲𝗱, 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵-𝗱𝗿𝗶𝘃𝗲𝗻 𝘀𝘁𝗮𝗿𝘁𝘂𝗽𝘀 is widening fast. We’re breaking down what’s happening — and what it means going forward — in our upcoming Startup Financing Trends webinar. 🎥 Join us here: https://lnkd.in/dfQUvEs7

Big News from TECH Fort Worth as it announces a partnership with BioNTX to help startups in biotech and life sciences. Robert Francis has the story at the Fort Worth Report. #TechFW #BioNTX https://lnkd.in/guB42G-2

Europe's university spinouts are rewriting the rules of tech innovation. A new report from Dealroom and Walden Catalyst shows a remarkable milestone: European university spinouts now have a combined valuation of €370 billion. This figure highlights the significant economic impact these startups have generated from academic research across the continent. The report also identifies ETH Zürich and EPFL as the leading hubs for deep tech founders worldwide. These Swiss institutions have outpaced traditional powerhouses like MIT and Stanford in recent years when it comes to the number of research-born startups created. This shift signals a broader change in the landscape of tech innovation. What makes these European universities so effective at fostering startups? The answer lies in strong collaboration between research, industry, and venture capital. Their ability to turn complex scientific advances into commercial ventures is setting new standards. For investors and entrepreneurs, this data offers clear insights. Europe is no longer just a follower in deep tech. It is a thriving incubator with significant value being created at universities. How should your business or investment strategy adapt to this changing innovation ecosystem? #DeepTech #Innovation #UniversitySpinouts #EuropeanTech #StartupEcosystem

🚀 From Lab to Launch: What Swiss Deep Tech Founders Actually Need to Scale Every week, brilliant ideas leave ETH Zurich's labs. But many get bogged down by delayed early stage funding and chasing non-dilutive solutions. Why? As a venture builder working daily at the intersection of science, capital, and execution, I see three recurring gaps that stop founders before they even reach Series A: 1️⃣ Premature scaling – Building teams and tech before validating the real customer problem. 2️⃣ Capital misalignment – Raising from the wrong investors too early, creating destructive incentives. 3️⃣ Regulatory blindness: Treating compliance as an afterthought instead of design guidelines. The data backs this up: 📊 The Swiss Biotech Report 2025 shows that while CHF 2.5B was raised in 2024 (+22% YoY), privately funded biotechs still struggle to cross the "valley of death" between proof-of-concept and clinical readiness. 📈 And the Swiss Deep Tech Report 2025 highlights that 60% of Swiss VC now flows into deep tech but commercialization remains the bottleneck. At NLC Health Ventures we've learned that venture building isn't just funding it's active de-risking: ✅ Co-defining the product-market fit before incorporation ✅ Embedding regulatory and reimbursement strategy from Day 1 ✅ Matching founders with operator-investors who've scaled in their domain   📚 Helpful resources for founders: Swiss Biotech Report 2025 (Swiss Biotech Association + EY) https://lnkd.in/eaHgBakt Swiss Deep Tech Report 2025 (Deep Tech Nation Switzerland) https://lnkd.in/ef9H9YmV Swiss Venture Capital Report 2025 (Startupticker.ch) https://lnkd.in/egvBevku "Deep Tech Play Book" by Patrick Griss (Zühlke Ventures) https://lnkd.in/euxCuebc   Let's connect if you're building in biotech or medtech and ready to move from interesting science to investable company.   #DeepTech #Biotech #VentureBuilding #ETHZurich #TechnologyEntrepreneurship #SwissStartups #Innovation #LifeSciences

Many ideas in life sciences start with strong science. The next step is learning how to turn that science into a company. That is where the BioBusiness Summer School 2026 can help. Leiden Bio Science Park is proud to support this program, and we would like to encourage startups and early-stage entrepreneurs in our community to take a look. Across five intensive days, founders and startup teams explore the practical side of building a biotech company. The program covers topics such as business models, IP strategy, product development, regulatory pathways, and financing. Sessions are led by experienced professionals from biotech, pharma, and venture capital, and combine lectures with case discussions and peer exchange. Just as important is the opportunity to meet others who are facing the same questions. You will spend the week alongside an international group of founders, researchers, and entrepreneurs working to translate scientific ideas into real-world solutions. If you are developing a technology, shaping a startup, or preparing for the next phase of growth, this program can help you sharpen your thinking and expand your network. Where: Amsterdam When: 22–26 June 2026 If this sounds relevant to you, take a look at the program. 👉 Learn more and apply here: https://lnkd.in/ddCFhyf And if you know other founders who might benefit, share this opportunity with them.

Deep-tech ventures face a distinct set of commercialisation risks as they move from research to market. Five common risks include: • Long and uncertain development cycles • Limited commercial experience within founding teams • High capital intensity • Challenges in achieving product–market fit • Regulatory and scaling complexities Understanding these risks is essential when designing appropriate support mechanisms and funding pathways for deep-tech teams. To explore these topics in more detail, watch: “Unlocking Innovation – The Foundations of Deep Tech”  https://lnkd.in/dhSJt8XG #DeepTech #Startup #Innovation #FutureTech #EuropeanDeepTechCommunity #Entrepreneur Munster Technological University, Institut Mines-Télécom Business School, Delft University of Technology, University of Ljubljana, Ege University, accent Inkubator GmbH, University Industry Innovation Network (UIIN), Crazy Town Oy, Momentum Educate + Innovate

Germany’s strongest deep tech startups are built on research that advances their field. But how do startups get access to that research? Startups who join our venture lab collaborate directly with one of the country’s leading applied research institutes, Fraunhofer Heinrich Hertz Institute HHI. On 11 March, we’re hosting a Live Q&A to explain to walk through: • What our newly launched CORE Topics actually are • How our venture lab works and what's on offer • IP, equity & funding • What we look for (and what we don’t) If you’re building in AI or deep tech and want to build on institution-grade research, this could be a great fit, join our session to find out more. https://luma.com/yupap155

Have a promising idea in life sciences but unsure how to move forward? Sci-ROI's webinar on "Deeptech Startups in India", is excellent opportunity to understand the pathways, support systems and next steps to get started.